Clinical benefit and radiological response with BRAF inhibitor in a patient with recurrent ameloblastoma harboring V600E mutation

por Fernandes, Gustavo S., Girardi, Daniel M., Bernardes, João Paulo G., Fonseca, Felipe P., Fregnani, Eduardo R.
Publicado 2018

Systemic Therapy for Advanced Hepatocellular Carcinoma: Current Stand and Perspectives

por Girardi, Daniel M., Sousa, Lara P., Miranda, Thiago A., Haum, Fernanda N. C., Pereira, Gabriel C. B., Pereira, Allan A. L.
Publicado 2023

Next-generation Sequencing-based genomic profiling: Fostering innovation in cancer care?

por Fernandes, Gustavo S., Marques, Daniel F., Girardi, Daniel M., Braghiroli, Maria Ignez F., Coudry, Renata A., Meireles, Sibele I., Katz, Artur, Hoff, Paulo M.
Publicado 2017

Immunotherapy and Targeted Therapy for Hepatocellular Carcinoma: A Literature Review and Treatment Perspectives

por Girardi, Daniel M., Pacífico, Jana Priscila M., Guedes de Amorim, Fernanda P. L., dos Santos Fernandes, Gustavo, Teixeira, Marcela C., Pereira, Allan A. L.
Publicado 2020

Chemoradiotherapy versus chemotherapy as adjuvant treatment for localized gastric cancer: a propensity score-matched analysis

por Girardi, Daniel M., de Lima, Mariana A., Pereira, Gabriel C. B., Negrão, Marcelo V., López, Rossana V. M., Capareli, Fernanda C., Sabbaga, Jorge, Hoff, Paulo Marcelo G.
Publicado 2018

Cabozantinib plus Nivolumab Phase I Expansion Study in Patients with Metastatic Urothelial Carcinoma Refractory to Immune Checkpoint Inhibitor Therapy

por Girardi, Daniel M., Niglio, Scot A., Mortazavi, Amir, Nadal, Rosa, Lara, Primo, Pal, Sumanta K., Saraiya, Biren, Cordes, Lisa, Ley, Lisa, Ortiz, Olena Sierra, Cadena, Jacqueline, Diaz, Carlos, Bagheri, Hadi, Redd, Bernadette, Steinberg, Seth M., Costello, Rene, Chan, Keith S., Lee, Min-Jung, Lee, Sunmin, Yu, Yunkai, Gurram, Sandeep, Chalfin, Heather J., Valera, Vladimir, Figg, William D., Merino, Maria, Toubaji, Antoun, Streicher, Howard, Wright, John J., Sharon, Elad, Parnes, Howard L., Ning, Yang-Min, Bottaro, Donald P., Cao, Liang, Trepel, Jane B., Apolo, Andrea B.
Publicado 2022

Phase I Study of Cabozantinib and Nivolumab Alone or With Ipilimumab for Advanced or Metastatic Urothelial Carcinoma and Other Genitourinary Tumors

por Apolo, Andrea B., Nadal, Rosa, Girardi, Daniel M., Niglio, Scot A., Ley, Lisa, Cordes, Lisa M., Steinberg, Seth M., Sierra Ortiz, Olena, Cadena, Jacqueline, Diaz, Carlos, Mallek, Marissa, Davarpanah, Nicole N., Costello, Rene, Trepel, Jane B., Lee, Min-Jung, Merino, Maria J., Bagheri, Mohammad Hadi, Monk, Paul, Figg, William D., Gulley, James L., Agarwal, Piyush K., Valera, Vladimir, Chalfin, Heather J., Jones, Jennifer, Streicher, Howard, Wright, John J., Ning, Yangmin M., Parnes, Howard L., Dahut, William L., Bottaro, Donald P., Lara, Primo N., Saraiya, Biren, Pal, Sumanta K., Stein, Mark N., Mortazavi, Amir
Publicado 2020